RE: Mgc could pivot to4 Nov 2021 21:26
CannEpil:
CannEpil® has been added to the Primary Care Reimbursement Service in the Republic of Ireland ("Ireland") as part of the Medicinal Cannabis Access Programme ("MCAP"), making it free of charge for Irish patients prescribed the treatment under the MCAP.
· CannEpil® is one of the first EU-GMP pharmaceutical grade cannabis medicine products to be approved for prescription in Ireland under the MCAP and under the Primary Care Reimbursement Service, which is part of Ireland's Heath Service Executive